SEC Form D private-offering filing

Vergent Bioscience, Inc.

Name: Vergent Bioscience, Inc. - new SEC Form D private-offering filing, Minneapolis, MN
Published: 2025-10-20

A new SEC Form D private-offering notice from Minneapolis, MN, a $31,957,273 filer-stated offering target in Biotech. The source filing is one click away.

Vergent Bioscience, Inc. site↗ Verified via SEC Form D

Clinical-stage biotech developing tumor-targeted fluorescent imaging agents to help surgeons visualize and remove cancer tissue during minimally invasive and robotic-assisted surgery, starting with lung cancer.

Filed 2025-10-20Filed to raise $31,957,273First money in 2025-10-07Raised so far $18,673,277HQ (as filed) Minneapolis, MNSector Biotech ✓Stage (inferred) GrowthCall status Call-ready

Source linked the Form D on EDGAR↗Website verified vergentbio.com↗Named in the filing 6 executives & directors

Open this row on the live feed →More new filings in Minnesota →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.